TABLE 2.
Comparison of pregnant women's serum total 25(OH)D, 25(OH)D2, 25(OH)D3, and 3-epi-25(OH)D3 concentrations across trimesters of pregnancy1
| First trimester (9.9–14.7 wk) | Second trimester (20.7–25.3 wk) | Third trimester (31.6–34.6 wk) | P value | |
|---|---|---|---|---|
| 25(OH)D2,2 nmol/L | 1.8 ± 0.9b | 2.2 ± 1.4a | 2.9 ± 2.2a | <0.0001 |
| 25(OH)D3, nmol/L | 65.7 ± 20.6b | 84.3 ± 30.9a | 85.3 ± 28.9a | <0.0001 |
| Total 25(OH)D, nmol/L | 67.5 ± 20.4b | 86.5 ± 30.9a | 88.3 ± 29.0a | <0.0001 |
| 3-epi-25(OH)D3,3 nmol/L | 3.0 ± 1.7 | 3.1 ± 2.4 | 3.8 ± 2.2 | 0.57 |
Values are means ± SDs, n = 79.
25(OH)D2 concentrations were under the detection limit of 3 nmol/L for 70, 60, and 44 participants in the first, second, and third trimesters, respectively. In those cases, a value of 1.5 nmol/L was used.
3-epi-25(OH)D3 concentrations were under the detection limit of 2.5 nmol/L for 31, 34, and 40 participants in the first, second, and third trimesters, respectively. In those cases, a value of 1.25 nmol/L was used. All P values refer to repeated-measures ANOVA adjusted for season at the time of sampling, prepregnancy BMI, and vitamin D intake from supplements. Labeled means in a row without a common letter differ, P < 0.05. 3-epi-25(OH)D3, 3-epi-25-hydroxyvitamin D3; 25(OH)D, 25-hydroxyvitamin D; 25(OH)D2, 25-hydroxyergocalciferol; 25(OH)D3, 25-hydroxycholecalciferol.